High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolaños-Meade, M Zahurak… - Blood, The Journal …, 2010 - ashpublications.org
Because of its potent immunosuppressive yet stem cell–sparing activity, high-dose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
[PDF][PDF] High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolanos-Meade, M Zahurak, AR Chen… - BLOOD, 2010 - academia.edu
Because of its potent immunosuppressive yet stem cell–sparing activity, highdose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
[HTML][HTML] High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolaños-Meade, M Zahurak, AR Chen… - Blood, 2010 - Elsevier
Because of its potent immunosuppressive yet stem cell–sparing activity, high-dose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolaños-Meade, M Zahurak, AR Chen… - Blood, 2010 - pure.johnshopkins.edu
Because of its potent immunosuppressive yet stem cell-sparing activity, high-dose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
[引用][C] High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L LUZNIK, J BOLANOS-MEADE, Y KASAMON… - Blood, 2010 - pascal-francis.inist.fr
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host
disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[HTML][HTML] High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolaños-Meade, M Zahurak, AR Chen… - Blood, 2010 - ncbi.nlm.nih.gov
Because of its potent immunosuppressive yet stem cell–sparing activity, high-dose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
[PDF][PDF] High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolanos-Meade, M Zahurak, AR Chen… - BLOOD, 2010 - researchgate.net
Because of its potent immunosuppressive yet stem cell–sparing activity, highdose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolaños-Meade, M Zahurak, AR Chen… - Blood, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Because of its potent immunosuppressive yet
stem cell–sparing activity, high-dose cyclophosphamide was tested as sole prophylaxis of …
stem cell–sparing activity, high-dose cyclophosphamide was tested as sole prophylaxis of …
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.
L Luznik, J Bolaños-Meade, M Zahurak, AR Chen… - Blood, 2010 - europepmc.org
Because of its potent immunosuppressive yet stem cell–sparing activity, high-dose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
L Luznik, J Bolaños-Meade, M Zahurak, AR Chen… - …, 2010 - pubmed.ncbi.nlm.nih.gov
Because of its potent immunosuppressive yet stem cell-sparing activity, high-dose
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …
cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after …